280 related articles for article (PubMed ID: 29267258)
1. Plasma Long Non-Coding RNA (lncRNA) GAS5 is a New Biomarker for Coronary Artery Disease.
Yin Q; Wu A; Liu M
Med Sci Monit; 2017 Dec; 23():6042-6048. PubMed ID: 29267258
[TBL] [Abstract][Full Text] [Related]
2. Long Non-Coding RNA (lncRNA) Growth Arrest Specific 5 (GAS5) Suppresses Esophageal Squamous Cell Carcinoma Cell Proliferation and Migration by Inactivating Phosphatidylinositol 3-kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Signaling Pathway.
Wang G; Sun J; Zhao H; Li H
Med Sci Monit; 2018 Oct; 24():7689-7696. PubMed ID: 30368517
[TBL] [Abstract][Full Text] [Related]
3. LncRNA TONSL-AS1 participates in coronary artery disease by interacting with miR-197.
Wu L; Tan G; Li X; Jiang X; Run B; Zhou W; Liao H
Microvasc Res; 2021 Jul; 136():104152. PubMed ID: 33662410
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of GAS5 inhibits abnormal activation of Wnt/β-catenin signaling pathway in myocardial tissues of rats with coronary artery disease.
Li X; Hou L; Cheng Z; Zhou S; Qi J; Cheng J
J Cell Physiol; 2019 Jul; 234(7):11348-11359. PubMed ID: 30511472
[TBL] [Abstract][Full Text] [Related]
5. Prognostic and predictive value of long non-coding RNA GAS5 and mircoRNA-221 in colorectal cancer and their effects on colorectal cancer cell proliferation, migration and invasion.
Liu L; Meng T; Yang XH; Sayim P; Lei C; Jin B; Ge L; Wang HJ
Cancer Biomark; 2018; 22(2):283-299. PubMed ID: 29630521
[TBL] [Abstract][Full Text] [Related]
6. The overexpression of lncRNA H19 as a diagnostic marker for coronary artery disease.
Xiong G; Jiang X; Song T
Rev Assoc Med Bras (1992); 2019 Feb; 65(2):110-117. PubMed ID: 30892430
[TBL] [Abstract][Full Text] [Related]
7. A novel plasma lncRNA ENST00000416361 is upregulated in coronary artery disease and is related to inflammation and lipid metabolism.
Li P; Yan X; Xu G; Pang Z; Weng J; Yin J; Li M; Yu L; Chen Q; Sun K
Mol Med Rep; 2020 Jun; 21(6):2375-2384. PubMed ID: 32323776
[TBL] [Abstract][Full Text] [Related]
8. The GAS5/miR-222 Axis Regulates Proliferation of Gastric Cancer Cells Through the PTEN/Akt/mTOR Pathway.
Li Y; Gu J; Lu H
Dig Dis Sci; 2017 Dec; 62(12):3426-3437. PubMed ID: 29098549
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of lncRNA OGFRP1 induces autophagy and growth inhibition by AKT/mTOR signaling pathway in HCAECs.
Zhang X; Liu J; Gu Y; Sun C; Qu F
Cell Biol Int; 2019 Feb; 43(2):158-166. PubMed ID: 30536541
[TBL] [Abstract][Full Text] [Related]
10. Circulating 'lncRNA OTTHUMT00000387022' from monocytes as a novel biomarker for coronary artery disease.
Cai Y; Yang Y; Chen X; Wu G; Zhang X; Liu Y; Yu J; Wang X; Fu J; Li C; Jose PA; Zeng C; Zhou L
Cardiovasc Res; 2016 Dec; 112(3):714-724. PubMed ID: 26857419
[TBL] [Abstract][Full Text] [Related]
11. Identification of a peripheral blood long non-coding RNA (Upperhand) as a potential diagnostic marker of coronary artery disease.
Li X; Zhao Z; Gao C; Rao L; Hao P; Jian D; Li W; Tang H; Li M
Cardiol J; 2018; 25(3):393-402. PubMed ID: 29168540
[TBL] [Abstract][Full Text] [Related]
12. Characterization of LncRNA expression profile and identification of novel LncRNA biomarkers to diagnose coronary artery disease.
Li L; Wang L; Li H; Han X; Chen S; Yang B; Hu Z; Zhu H; Cai C; Chen J; Li X; Huang J; Gu D
Atherosclerosis; 2018 Aug; 275():359-367. PubMed ID: 30015300
[TBL] [Abstract][Full Text] [Related]
13. NEAT1/miR-140-3p/MAPK1 mediates the viability and survival of coronary endothelial cells and affects coronary atherosclerotic heart disease.
Zhang H; Ji N; Gong X; Ni S; Wang Y
Acta Biochim Biophys Sin (Shanghai); 2020 Sep; 52(9):967-974. PubMed ID: 32844995
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA growth arrest-specific 5 facilitates glioma cell sensitivity to cisplatin by suppressing excessive autophagy in an mTOR-dependent manner.
Huo JF; Chen XB
J Cell Biochem; 2019 Apr; 120(4):6127-6136. PubMed ID: 30317677
[TBL] [Abstract][Full Text] [Related]
15. lncRNA GAS5 inhibits malignant progression by regulating macroautophagy and forms a negative feedback regulatory loop with the miR‑34a/mTOR/SIRT1 pathway in colorectal cancer.
Zhang HG; Wang FJ; Wang Y; Zhao ZX; Qiao PF
Oncol Rep; 2021 Jan; 45(1):202-216. PubMed ID: 33416133
[TBL] [Abstract][Full Text] [Related]
16. Decreased expression of lncRNA GAS5 predicts a poor prognosis in cervical cancer.
Cao S; Liu W; Li F; Zhao W; Qin C
Int J Clin Exp Pathol; 2014; 7(10):6776-83. PubMed ID: 25400758
[TBL] [Abstract][Full Text] [Related]
17. Circulating lncRNA IFNG-AS1 expression correlates with increased disease risk, higher disease severity and elevated inflammation in patients with coronary artery disease.
Xu Y; Shao B
J Clin Lab Anal; 2018 Sep; 32(7):e22452. PubMed ID: 29744951
[TBL] [Abstract][Full Text] [Related]
18. Reciprocal regulation of GAS5 lncRNA levels and mTOR inhibitor action in prostate cancer cells.
Yacqub-Usman K; Pickard MR; Williams GT
Prostate; 2015 May; 75(7):693-705. PubMed ID: 25650269
[TBL] [Abstract][Full Text] [Related]
19. Epigenetically-regulated serum GAS5 as a potential biomarker for patients with chronic hepatitis B virus infection.
Guo Y; Li C; Zhang R; Zhan Y; Yu J; Tu J; Zheng J
Cancer Biomark; 2021; 32(2):137-146. PubMed ID: 34092613
[TBL] [Abstract][Full Text] [Related]
20. Tumor-derived exosomal lncRNA GAS5 as a biomarker for early-stage non-small-cell lung cancer diagnosis.
Li C; Lv Y; Shao C; Chen C; Zhang T; Wei Y; Fan H; Lv T; Liu H; Song Y
J Cell Physiol; 2019 Nov; 234(11):20721-20727. PubMed ID: 31032916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
